Centre Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$3.16M Sell
19,073
-61,587
-76% -$9.64M 0.81% 41
2024
Q4
$11.7M Sell
80,660
-7,865
-9% -$1.22M 2.67% 7
2024
Q3
$14.3M Buy
88,525
+616
+0.7% +$98.1K 3.09% 7
2024
Q2
$12.8M Buy
87,909
+15,037
+21% +$2.24M 2.95% 6
2024
Q1
$11.5M Sell
72,872
-13,248
-15% -$2.11M 2.75% 11
2023
Q4
$13.5M Buy
86,120
+56,400
+190% +$8.65M 3.26% 5
2023
Q3
$4.63M Sell
29,720
-1,034
-3% -$171K 1.13% 34
2023
Q2
$5.09M Buy
30,754
+812
+3% +$131K 1.13% 35
2023
Q1
$4.64M Buy
29,942
+460
+2% +$74.3K 1.12% 38
2022
Q4
$5.21M Buy
29,482
+1,581
+6% +$273K 1.38% 39
2022
Q3
$4.56M Sell
27,901
-46
-0.2% -$7.78K 1.26% 35
2022
Q2
$4.96M Buy
27,947
+8,423
+43% +$1.5M 1.32% 31
2022
Q1
$3.46M Buy
+19,524
New +$3.32M 1.09% 35
2021
Q3
Sell
-13,580
Closed -$2.24M 60
2021
Q2
$2.24M Sell
13,580
-3,220
-19% -$533K 1.16% 40
2021
Q1
$2.76M Sell
16,800
-6,610
-28% -$1.07M 1.27% 35
2020
Q4
$3.68M Buy
23,410
+4,440
+23% +$655K 1.73% 26
2020
Q3
$2.82M Buy
18,970
+2,190
+13% +$324K 0.92% 41
2020
Q2
$2.36M Sell
16,780
-10,610
-39% -$1.55M 0.97% 40
2020
Q1
$3.59M Sell
27,390
-3,810
-12% -$541K 1.1% 34
2019
Q4
$4.55M Sell
31,200
-113,610
-78% -$15.4M 1.07% 33
2019
Q3
$18.7M Buy
144,810
+90,610
+167% +$11.9M 4.32% 4
2019
Q2
$7.55M Buy
54,200
+3,760
+7% +$520K 1.82% 30
2019
Q1
$7.05M Sell
50,440
-45,590
-47% -$6.11M 1.83% 25
2018
Q4
$12.4M Buy
96,030
+48,140
+101% +$6.72M 3.65% 3
2018
Q3
$6.62M Sell
47,890
-2,470
-5% -$328K 1.54% 31
2018
Q2
$6.11M Sell
50,360
-3,550
-7% -$443K 1.43% 37
2018
Q1
$6.91M Sell
53,910
-4,360
-7% -$589K 1.6% 28
2017
Q4
$8.14M Sell
58,270
-32,250
-36% -$4.49M 1.98% 22
2017
Q3
$11.8M Sell
90,520
-1,020
-1% -$135K 3.05% 10
2017
Q2
$12.1M Buy
91,540
+2,980
+3% +$380K 3.23% 7
2017
Q1
$11M Sell
88,560
-26,230
-23% -$3.13M 3.03% 5
2016
Q4
$13.2M Sell
114,790
-15,830
-12% -$1.83M 2.55% 8
2016
Q3
$15.4M Sell
130,620
-66,470
-34% -$8.06M 2.8% 10
2016
Q2
$23.9M Buy
197,090
+15,200
+8% +$1.73M 4.23% 3
2016
Q1
$19.7M Buy
181,890
+54,070
+42% +$5.6M 3.43% 4
2015
Q4
$13.1M Sell
127,820
-63,410
-33% -$6.38M 2.25% 13
2015
Q3
$17.9M Buy
191,230
+54,370
+40% +$5.26M 3.09% 4
2015
Q2
$13.3M Buy
136,860
+22,080
+19% +$2.21M 2.1% 8
2015
Q1
$11.5M Buy
114,780
+7,410
+7% +$754K 1.71% 20
2014
Q4
$11.2M Sell
107,370
-51,440
-32% -$5.42M 1.74% 17
2014
Q3
$16.9M Sell
158,810
-40,472
-20% -$4.2M 2.59% 5
2014
Q2
$20.8M Sell
199,282
-6,630
-3% -$670K 3.14% 4
2014
Q1
$20.2M Buy
205,912
+2,000
+1% +$185K 2.99% 4
2013
Q4
$18.7M Buy
203,912
+53,530
+36% +$4.93M 2.89% 4
2013
Q3
$13M Sell
150,382
-111,030
-42% -$9.96M 2.07% 10
2013
Q2
$22.4M Buy
+261,412
New +$22.2M 3.65% 2

Other funds holding JNJ

Centre Asset Management's JNJ Position: Q1 2025 in Review

Centre Asset Management reduced its Johnson & Johnson (JNJ) stake by 76% in Q1 2025, selling an estimated $9.64M and leaving 19,073 shares worth $3.16M. The position accounts for 0.81% of the portfolio, ranked #41.

Centre Asset Management first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $23.9M in Q2 2016. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Centre Asset Management held 19,073 shares of Johnson & Johnson worth $3.16M as of Q1 2025.
  • Centre Asset Management sold 61,587 Johnson & Johnson shares in Q1 2025, an estimated $9.64M.
  • Johnson & Johnson made up 0.81% of Centre Asset Management's portfolio in Q1 2025, its #41 holding.
  • Centre Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • Centre Asset Management's Johnson & Johnson position peaked at $23.9M in Q2 2016.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Centre Asset Management's 13F filing for Q1 2025, filed 1 Apr 2025.